Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GUTS NASDAQ:RCEL NASDAQ:STEX NASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUTSFractyl Health$0.76-2.3%$0.81$0.38▼$2.45$121.37M2.293.59 million shs1.54 million shsRCELAvita Medical$5.22+1.6%$4.33$3.22▼$7.12$160.40M1.86262,089 shs69,712 shsSTEXBiosig Technologies$0.80+3.3%$1.01$0.70▼$7.44$144.71M1.941.86 million shs532,113 shsSTRRStar Equity$11.09-0.6%$11.06$8.38▼$11.99$41.01M0.517,643 shs4,255 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUTSFractyl Health-3.60%+2.51%-7.60%+35.79%-56.38%RCELAvita Medical+0.78%+30.13%+28.18%+7.76%-0.58%STEXBiosig Technologies-0.88%-7.58%-15.21%-22.37%+77,629,900.00%STRRStar Equity+1.30%+0.94%-0.92%+20.66%+469.52%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUTSFractyl Health$0.76-2.3%$0.81$0.38▼$2.45$121.37M2.293.59 million shs1.54 million shsRCELAvita Medical$5.22+1.6%$4.33$3.22▼$7.12$160.40M1.86262,089 shs69,712 shsSTEXBiosig Technologies$0.80+3.3%$1.01$0.70▼$7.44$144.71M1.941.86 million shs532,113 shsSTRRStar Equity$11.09-0.6%$11.06$8.38▼$11.99$41.01M0.517,643 shs4,255 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUTSFractyl Health-3.60%+2.51%-7.60%+35.79%-56.38%RCELAvita Medical+0.78%+30.13%+28.18%+7.76%-0.58%STEXBiosig Technologies-0.88%-7.58%-15.21%-22.37%+77,629,900.00%STRRStar Equity+1.30%+0.94%-0.92%+20.66%+469.52%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGUTSFractyl Health 2.50Moderate Buy$5.12571.04% UpsideRCELAvita Medical 2.43Hold$7.2538.89% UpsideSTEXBiosig Technologies 2.00Hold$8.00897.51% UpsideSTRRStar Equity 2.20Hold$28.00152.59% UpsideCurrent Analyst Ratings BreakdownLatest STRR, STEX, RCEL, and GUTS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/6/2026GUTSFractyl Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)7/1/2026GUTSFractyl Health Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.007/1/2026GUTSFractyl Health Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.006/30/2026RCELAvita Medical TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/24/2026RCELAvita Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/4/2026GUTSFractyl Health HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.005/21/2026STEXBiosig Technologies Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.005/20/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/20/2026STRRStar Equity Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/15/2026RCELAvita Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$3.50 ➝ $6.005/12/2026GUTSFractyl Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGUTSFractyl Health$90K1,345.00N/AN/A$0.07 per share10.90RCELAvita Medical$71.61M2.24N/AN/A($0.55) per share-9.49STEXBiosig Technologies$40K3,645.09N/AN/A$0.83 per share0.97STRRStar Equity$172.16M0.24$0.63 per share17.61$19.12 per share0.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGUTSFractyl Health-$140.95M-$1.29N/AN/AN/AN/A-4,053.15%-96.41%8/11/2026 (Estimated)RCELAvita Medical-$48.59M-$1.57N/AN/AN/A-62.67%N/A-78.92%8/6/2026 (Estimated)STEXBiosig Technologies-$462.77M-$9.71N/AN/AN/AN/A-717.92%-336.75%N/ASTRRStar Equity-$5.92M-$2.63N/A10.66N/A-4.18%-4.04%-2.40%8/6/2026 (Estimated)Latest STRR, STEX, RCEL, and GUTS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026Q2 2026GUTSFractyl Health-$0.15N/AN/AN/AN/AN/A8/6/2026Q2 2026RCELAvita Medical-$0.2928N/AN/AN/A$20.25 millionN/A8/6/2026N/ASTRRStar Equity-$0.07N/AN/AN/A$56.92 millionN/A5/14/2026Q1 2026RCELAvita Medical-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million5/14/2026Q1 2026STEXBiosig TechnologiesN/A-$0.27N/A-$0.27N/AN/A5/12/2026Q1 2026GUTSFractyl Health-$0.17$0.06+$0.23$0.06N/AN/A5/11/2026Q1 2026STRRStar Equity$0.05-$0.99-$1.04-$1.17$52.57 million$50.06 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGUTSFractyl HealthN/AN/AN/AN/AN/ARCELAvita MedicalN/AN/AN/AN/AN/ASTEXBiosig TechnologiesN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGUTSFractyl Health1.414.284.28RCELAvita MedicalN/A0.470.38STEXBiosig TechnologiesN/A13.9013.90STRRStar Equity0.092.091.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGUTSFractyl HealthN/ARCELAvita Medical27.66%STEXBiosig Technologies7.16%STRRStar Equity3.84%Insider OwnershipCompanyInsider OwnershipGUTSFractyl Health8.52%RCELAvita Medical2.24%STEXBiosig Technologies52.73%STRRStar Equity31.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGUTSFractyl Health102158.65 million145.13 millionN/ARCELAvita Medical13030.78 million30.09 millionOptionableSTEXBiosig Technologies50181.80 million85.94 millionN/ASTRRStar Equity1,2003.70 million2.53 millionNot OptionableSTRR, STEX, RCEL, and GUTS HeadlinesRecent News About These CompaniesStar Equity Holdings Added to the Russell Microcap® IndexJune 29, 2026 | globenewswire.comInsider Buying: Star Equity (NASDAQ:STRR) CEO Acquires 4,766 Shares of StockJune 24, 2026 | insidertrades.comJeffrey Eberwein Acquires 4,994 Shares of Star Equity (NASDAQ:STRR) StockJune 18, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) CEO Jeffrey Eberwein Purchases 1,884 SharesJune 13, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) CEO Jeffrey Eberwein Purchases 2,849 SharesJune 10, 2026 | insidertrades.comJeffrey Eberwein Purchases 1,430 Shares of Star Equity (NASDAQ:STRR) StockJune 5, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) Director Acquires $11,600.00 in StockJune 3, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) CEO Acquires $17,176.38 in StockJune 2, 2026 | insidertrades.comStar Equity Holdings, Inc. to Present at Noble Capital Markets Emerging Growth Virtual Conference on June 3-4, 2026June 1, 2026 | quiverquant.comQStar Equity Holdings to Present at the Noble Capital Markets Emerging Growth Virtual Conference on June 3-4June 1, 2026 | globenewswire.comStar Equity (NASDAQ:STRR) CEO Buys $26,906.88 in StockMay 28, 2026 | insidertrades.comInsider Stock Buying Reaches US$4.21m On Star Equity HoldingsMay 22, 2026 | finance.yahoo.comInsider Buying: Star Equity (NASDAQ:STRR) CEO Buys 4,198 Shares of StockMay 22, 2026 | insidertrades.comStar Equity Launches ATM Preferred Stock Offering ProgramMay 18, 2026 | tipranks.comStar Equity Declares Cash Dividend on Preferred StockMay 15, 2026 | tipranks.comStar Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred StockMay 15, 2026 | globenewswire.comStar Equity Holdings: Q1 Earnings SnapshotMay 11, 2026 | khou.comKStar Equity Holdings (STRR) Reports Q1 Loss, Misses Revenue EstimatesMay 11, 2026 | zacks.comStar Equity Holdings Reports Strong Q1 Revenue Growth and Achieves $2.6 Million in Merger SynergiesMay 11, 2026 | quiverquant.comQStar Equity Holdings Reports 2026 First Quarter ResultsMay 11, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Micron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 20263 European Stocks to Carry Investors Through the Back Half of 2026By Chris Markoch | July 1, 2026STRR, STEX, RCEL, and GUTS Company DescriptionsFractyl Health NASDAQ:GUTS$0.76 -0.02 (-2.41%) As of 02:12 PM Eastern This is a fair market value price provided by Massive. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.Avita Medical NASDAQ:RCEL$5.22 +0.08 (+1.56%) As of 02:11 PM Eastern This is a fair market value price provided by Massive. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Biosig Technologies NASDAQ:STEX$0.80 +0.02 (+3.18%) As of 02:11 PM Eastern This is a fair market value price provided by Massive. Learn more.BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Star Equity NASDAQ:STRR$11.09 -0.06 (-0.52%) As of 02:12 PM Eastern This is a fair market value price provided by Massive. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Is Planning a New AI Chip. Here's Why It Matters Ahead of Earnings Industrial and Utility Giants Boost Dividends as Data Center Tailwinds Build IREN’s $2.8 Billion AI Contract Haul Changes the Stock’s Story 2 ETFs to Access the World's Best-Performing Stock Markets In 2026 Microsoft's AI Bet Could Rewrite AMD's Growth Story Buy, Hold, or Wait: 3 Small-Cap Stocks Telling Different Stories The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino's Stock Serving Up a Buying Opportunity? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
